Careseng Cancer Therapy

Careseng is a specially formulated non toxic ginseng product that is given intravenously for the treatment of cancer.  Careseng is a commercially prepared product produced from ginseng that contains greater than 99% anti-cancer ginsengosides. The two main anti-cancer compounds of Careseng, Rh2 and aglycon sapogenins, have shown in initial clinical trials to have strong cancer-inhibitory effects. Laboratory data and preliminary clinical observation strongly indicate that in combination with conventional chemotherapy, the ginsengosides dramatically sensitize cancer cells to conventional treatments.

For thousands of years, ginseng (Panax Quinquefolium L.) preparations have been used to treat all kinds of health maladies. The main ingredients in ginseng found to have therapeutic activity are Ginseng saponins (ginsenosides), but only few of these ginsenosides, notably Rh1/2 and Rg3, demonstrate the ability to kill cancer cells. Since most ginseng preparations contain only trace amounts of these anticancer compounds, the ability to halt cancer cell growth is limited with regular ginseng extracts.

Recent studies on the specially formulated ginseng product, Careseng®, containing over 80% of Rh2 and Rh2-like ginsenosides, was tested on cultured breast, prostate, lung, pancreatic and brain cancer cells and in an intracranial glioma rat model.  The results concluded that Careseng does have anticancer properties and further clinical studies were recommended.

Indications

• People with multi-drug resistant cancer cells
• People with late stage cancer

Links
www.careseng.com

Questions?
If you have any questions about Careseng Therapy or would like more information on our programs or services, you can contact IMI at 403.233.0917 or by email at info@i-medi.org